Trial
NCT04634110
Brigatinib Before Brain Irradiation Trial (B3i Trial)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
National Cancer Institute (NCI)
Condition
Brain Metastases
Intervention
Brigatinib
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-24